Purchase Order 1232SC18P0163
- Not listed
- This federal contract award, valued at $10,000.00, was issued by the United States Department of Agriculture (USDA) Forest Service Research Service Rocky Mountain Research Station to Psomagen Inc., a subsidiary of Macrogen, Inc. The contract is for DNA sequencing services with a completion date of September 5, 2025. Psomagen Inc. is a provider of genomic and molecular biology services to various federal agencies, including the National Institutes of Health (NIH) and the USDA. The company has...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $10,000.00 firm fixed-price purchase order is for DNA sequencing services. The contract has no set-aside designation. Psomagen Inc. is a provider of genomic and molecular biology services, including whole genome sequencing, RNA sequencing, and epigenome sequencing, that supports...
- This federal contract represents a ratifying order for sequencing services awarded to Psomagen Inc., a genomics and molecular biology services company subsidiary of Macrogen, Inc., on April 10, 2018. The purchase order carries a ceiling value of $2,718.65 under a firm fixed-price contract type with no set-aside designation. The work will be performed in Potomac, Maryland, and is funded by a civilian federal agency's Southeast Area office. Psomagen specializes in advanced genomic sequencing,...
- This federal contract award, valued at $9,970.00, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Psomagen Inc., a subsidiary of Macrogen, Inc. The contract is for the provision of genomic and molecular biology services, including whole genome sequencing, RNA sequencing, and epigenome sequencing, to support research initiatives. Psomagen Inc. has established itself as a key provider of genomic services to various federal agencies, particularly within...
- This federal contract award, valued at $118,650.00, was made by the National Institute of Child Health and Human Development to Psomagen Inc., a subsidiary of Macrogen, Inc. The contract is for sequencing services to support whole exome sequencing research. The award did not have a set-aside designation. Psomagen Inc. is a provider of advanced genomic and molecular biology services to federal agencies, including the National Institutes of Health, U.S. Department of Agriculture, and Smithsonian...
- This federal contract award, with a ceiling value of $27,600, was issued by the National Institute of Mental Health (NIMHD) to Psomagen Inc., a subsidiary of Macrogen, Inc. The contract is for bioinformatics services related to RNA/DNA sequencing. Psomagen, a small business, has a history of providing genomic services to various federal agencies, including the National Institutes of Health (NIH), U.S. Department of Agriculture (USDA), and Smithsonian Institution, through both contract and...
- This federal contract award was issued by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $4,250 firm fixed-price purchase order was for unspecified genomic and molecular biology services to support research initiatives at NHGRI. Psomagen Inc. has established itself as a key provider of advanced sequencing and omics capabilities to federal agencies, having been awarded numerous...
- This federal contract award to Psomagen Inc., a subsidiary of Macrogen, Inc., is for epigenome sequencing services using the Illumina NovaSeq platform. The $83,750 firm fixed-price purchase order was awarded by the National Institute on Aging, a civilian agency within the National Institutes of Health. The award was not set aside for small businesses. Psomagen Inc. is an experienced provider of genomic services to federal agencies, having supported research initiatives at the NIH, USDA, and...
- This federal contract award to Psomagen Inc., a subsidiary of Macrogen, Inc., is for DNA sequencing and genetic marker analysis services to support multi-year research by the U.S. Forest Service Research Service Rocky Mountain Research Station, a civilian agency. The $10,000 firm-fixed-price contract, awarded on August 12, 2020, does not have a set-aside designation. Psomagen Inc. has a history of providing genomic services to various government agencies, including the National Institutes of...
- This federal contract award was issued by the U.S. Department of Agriculture (USDA) Forest Service Research Service Rocky Mountain Research Station to Psomagen Inc., a subsidiary of Macrogen, Inc. The $19,997.50 firm fixed-price purchase order is for DNA sequencing services to be performed in Moscow, Idaho by the October 7, 2023 completion date. The award does not have a set-aside designation. Psomagen Inc. is a for-profit genomics and molecular biology services company that has previously...
This federal contract award, with an ID of 1232SC18P0163, was issued by the Southeast Area division of a civilian federal agency to Psomagen Inc., a subsidiary of Macrogen, Inc. The award, valued at $9,990.00, is for plasmid/PCR product sequencing services and has no set-aside designation. Psomagen Inc. is a provider of advanced genomic and molecular biology services, including whole genome sequencing, RNA sequencing, and epigenome sequencing, to various federal agencies such as the National Institutes of Health (NIH) and the U.S. Department of Agriculture (USDA). The company holds two significant Indefinite Delivery Vehicles (IDVs) - one with the USDA's Animal and Plant Health Inspection Service for Sanger sequencing to identify intercepted pests, and another with the NIH's National Heart, Lung and Blood Institute to establish and operate the Centralized Omics Resource for the Trans-Omics for Precision Medicine (TOPMed) initiative, valued at up to $500 million.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($10) | 1/14/20 | |
| Not listed | Not listed | $10.0k | 3/16/18 |